Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Study Information
Alliance Study ID: NCCTG-N02C2
NCT Study ID (ClinicalTrials.gov): NCT00058331
Disease or Cancer Type: Solid Tumors
Alliance Study Chair: David P. Steensma, MD
Status: COMPLETED
Study Description
RATIONALE: Epoetin alfa may stimulate red blood cell production and treat anemia in patients with solid tumors. It is not yet known whether epoetin alfa given once a week is more effective than epoetin alfa given once every 3 weeks in treating anemia.
PURPOSE: Randomized phase III trial to study the effectiveness of epoetin alfa in treating anemia in patients who have solid tumors.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information